TRDA Stock Summary and Trading Ideas (Entrada Therapeutics | NASDAQ:TRDA)

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Entrada Therapeutics trades on the NASDAQ stock market under the symbol TRDA.

As of March 20, 2026, TRDA stock price declined to $11.31 with 306,929 million shares trading.

TRDA has a beta of 1.00, meaning it tends to be less sensitive to market movements. TRDA has a correlation of 0.09 to the broad based SPY ETF.

TRDA has a market cap of $432.26 million. This is considered a Small Cap stock.

Last quarter Entrada Therapeutics reported $1 million in Revenue and -$.94 earnings per share. This fell short of revenue expectation by $-4 million and exceeded earnings estimates by $.28.

In the last 3 years, TRDA traded as high as $21.79 and as low as $4.93.

The top ETF exchange traded funds that TRDA belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.

TRDA has underperformed the market in the last year with a price return of +8.6% while the SPY ETF gained +16.6%. However, in the short term, TRDA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +3.0% vs -4.4% return in SPY. But in the last 2 weeks, TRDA shares have been beat by the market, returning -10.1% compared to an SPY return of -3.3%.

TRDA support price is $11.36 and resistance is $12.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TRDA shares will trade within this expected range on the day.